The US Women's Health Initiative tr...
The US Women's Health Initiative trial of combined hormone replacement therapy (HRT) was highly publicly halted in 2002 owing to an increased risk of heart disease. however 23 previous small trials done by the agency of pharmaceutical companies, some in no degree released, showed a lack of protection compared to the observational data. Those findings, published in a British Medical Journal analysis on Klim McPherson and Elina Hemminki, were called "Synthesising Licensing
|